Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 356 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Legal Officer gave up 277 shares (to pay taxes)
  3. 4 Shares withheld for taxes President and CEO gave up 782 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Financial Officer gave up 370 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Legal Officer gave up 497 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes Chief Medical Officer gave up 1,648 shares (to pay taxes)
  10. 4 Open-market sale 10% owner sold 699,475 shares at $2.69 ($1,882,077)
  11. 4 Open-market sale 10% owner sold 1,704 shares at $4.50 ($7,671)
  12. 4 Open-market sale 10% owner sold 454,261 shares at an average $4.59 ($2,085,238)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale 10% owner sold 614,710 shares at an average $6.13 ($3,765,522)
  20. 4 Derivatives Options or other derivatives

Page 13 of 21 · 414 filings